2021
DOI: 10.1016/j.ejphar.2021.174042
|View full text |Cite
|
Sign up to set email alerts
|

Nifuroxazide improves insulin secretion and attenuates high glucose-induced inflammation and apoptosis in INS-1 cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 41 publications
0
6
0
Order By: Relevance
“…The reason may be related to the fact that the glucose concentration of 4.5 g/L is higher than the normal blood glucose concentration in vivo when the carbon source is not depleted ( Li et al., 2022 ). Besides, 1 g/L was also used in many SC studies as the control group ( Yuan et al., 2022 ; Liu et al., 2021 ). Therefore, we think it is more reasonable to use 1 g/L as the control in the subsequent experiment.…”
Section: Discussionmentioning
confidence: 99%
“…The reason may be related to the fact that the glucose concentration of 4.5 g/L is higher than the normal blood glucose concentration in vivo when the carbon source is not depleted ( Li et al., 2022 ). Besides, 1 g/L was also used in many SC studies as the control group ( Yuan et al., 2022 ; Liu et al., 2021 ). Therefore, we think it is more reasonable to use 1 g/L as the control in the subsequent experiment.…”
Section: Discussionmentioning
confidence: 99%
“…Numerous published data have documented the anti-cancer activity of nifuroxazide and nitrofuran derivatives [7,8]. In addition, the possible use of nifuroxazide in the treatment of some inflammatory diseases was also reported [9][10][11][12][13].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, the anti-cancer activity of nifuroxazide and nitrofuran derivatives has also been documented [12]. It can also be used in the treatment of some inflammatory diseases [13,14].…”
Section: Introductionmentioning
confidence: 99%